Navigation Links
AXIOM Systems, Inc. Announces General Release of HIPAA 5010 Testing Solutions
Date:1/20/2010

FREDERICK, Md., Jan. 20 /PRNewswire/ -- AXIOM Systems, Inc. (AXIOM), considered the "Healthcare IT Industry Experts", today announced the general release of products and services that assist organizations in the testing of HIPAA 5010.

The HIPAA 5010 initiative requires extensive testing of internal processes and external trading partner capabilities due to the large number of format changes; it imposes a larger challenge, to test the business impacts inherent in the 5010 regulation changes.

To address this unique need AXIOM has released the following solutions:

4010 to 5010 Data Converter Utility -- This converter utility provides the ability to convert current production 4010 input files to a 5010 "state" in order to gain a significant head start to an organizations internal testing requirements.

TransSend Testing Module -- This application accepts all inbound and outbound HIPAA X12 transaction files and allows users to create and modify HIPAA 5010 transactions using intuitive browser based screens to support the creation of test cases and to manage their status from end to end.  The application can be deployed as a hosted service or installed locally.

5010 Packaged Test Scenarios -- AXIOM's Healthcare Subject Matter Experts have created a pre-packaged set of test scenarios and test case variations for each of the HIPAA transaction sets affected by 5010.  These test cases are intended to test those business areas impacted by the 5010 regulatory changes.

Test Planning and Execution Services -- These services leverage AXIOM's deep domain and skill set within the Healthcare industry and provides an organization both the process and expertise required to successfully test the requirements related to the 5010 mandates.  AXIOM's test methodology provides clients with a consistent and organized approach to both internal and external trading partner testing.

Trading Partner Management Services, utilizes AXIOM's Trading Partner Implementation Methodology to address the specific needs of external Trading Partner testing which is critical in the implementation of HIPAA 5010.

"Our HIPAA 5010 Testing Solutions are intended to provide an organization with the deep industry skill set and domain required to achieve a successful HIPAA 5010 compliance strategy while providing tools and products which insure a structured approach in dealing with the requirements of testing related to 5010", noted Richard Howe, CEO of AXIOM.

AXIOM considered the "Healthcare IT Industry Experts" is a privately held information technology firm, based in Frederick MD, which specializes in delivering an array of healthcare IT services and products.  Its services are driven by the firm's extensive knowledge of the "business of healthcare" and detailed understanding of the regulatory and technology issues that drive initiatives.  This hands on experience and industry exposure has provided the AXIOM team with the knowledge of best practices in the industry required to deliver high quality service.  From initial planning through solution implementation, AXIOM offers unparalleled expertise to assist Clients in making the right decisions.  

SOURCE AXIOM Systems, Inc.

RELATED LINKS
http://www.axiom-systems.com

'/>"/>

SOURCE AXIOM Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. AXIOM Selects Foresight Corp. for Integration Partnership
2. Axiom Named to Healthcare Informatics Top 100 List
3. Axiom Consulting Partners Announces the Results of its Return On Sales Investment Survey
4. Global Decompression Announces C.O.D. Available on All Used Axiom DRX 9000 Spinal Decompression Systems
5. WorldatWork Publishes Axiom Consulting Partners' Article on ‘Planning for the New Normal', an Alternative Approach to Compensation Planning
6. Axiom Worldwide Convicted of Infringing a Hako-Med Patent
7. Axiom Accelerated Patient Recruitment Rolls Out
8. AdCare Health Systems, Inc. Reports Discontinuation of Definitive Merger Agreement with Family Home Health Services, Inc.
9. Arbios Systems, Incs Q2/07 Analyst Review Issued by Scimitar Equity Research, Inc.
10. CAS Medical Systems, Inc. Awarded $2.8 Million Grant by National Institutes of Health
11. Mediware Information Systems, Inc. Receives Notice from the Nasdaq Stock Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: